HawaiiSCR 182025–2026 Regular Session (Year 2)Senate

REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

Sponsored By: Kurt Fevella (Republican)

In Committee

HealthMedicaidInsuranceKetamine TherapyAuditorReportHHS, WAM

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Kurt Fevella

    Republican • Senate

Cosponsors

  • Jarrett Keohokalole

    Democratic • Senate

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. The committee on HHS deferred the measure.

    3/30/2026Senate
  2. The committee(s) on HHS has scheduled a public hearing on 03-30-26 1:07PM; Conference Room 225 & Videoconference.

    3/27/2026Senate
  3. Referred to HHS, WAM.

    2/13/2026Senate
  4. Offered.

    2/6/2026Senate

Bill Text

Related Bills

Back to State Legislation